Sun Pharma inks agreement to buy US-based Organon for $11.75 billion
Summary
The transaction has been approved by the boards of both Sun Pharma and Organon, and is expected to close in early 2027, pending closing conditions such as regul...
Description
The transaction has been approved by the boards of both Sun Pharma and Organon, and is expected to close in early 2027, pending closing conditions such as regul...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source